Medicina ClinicaPub Date : 2024-12-27Epub Date: 2024-09-13DOI: 10.1016/j.medcli.2024.07.003
Cristina Candal-Pedreira, Joseph S Ross, Julia Rey-Brandariz, Alberto Ruano-Ravina
{"title":"Retraction of publications in Spain: A retrospective analysis using the Retraction Watch database.","authors":"Cristina Candal-Pedreira, Joseph S Ross, Julia Rey-Brandariz, Alberto Ruano-Ravina","doi":"10.1016/j.medcli.2024.07.003","DOIUrl":"10.1016/j.medcli.2024.07.003","url":null,"abstract":"","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":" ","pages":"626-633"},"PeriodicalIF":2.6,"publicationDate":"2024-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142291198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Medicina ClinicaPub Date : 2024-12-27Epub Date: 2024-09-07DOI: 10.1016/j.medcli.2024.06.015
Jose Pablo Serrano Serra, Javier Ruiz Martínez, José Francisco Orts Paco
{"title":"Multicentric reticulohistiocytosis with good response to tocilizumab.","authors":"Jose Pablo Serrano Serra, Javier Ruiz Martínez, José Francisco Orts Paco","doi":"10.1016/j.medcli.2024.06.015","DOIUrl":"10.1016/j.medcli.2024.06.015","url":null,"abstract":"","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":" ","pages":"636-637"},"PeriodicalIF":2.6,"publicationDate":"2024-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142154546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Medicina ClinicaPub Date : 2024-12-27Epub Date: 2024-09-28DOI: 10.1016/j.medcli.2024.07.013
Lucía Isabel Martínez Minuesa, Alba Manuel Vázquez, José Luis Ramos Rodríguez
{"title":"Syphilis as a cause of rectal tumour in an HIV-infected patient.","authors":"Lucía Isabel Martínez Minuesa, Alba Manuel Vázquez, José Luis Ramos Rodríguez","doi":"10.1016/j.medcli.2024.07.013","DOIUrl":"10.1016/j.medcli.2024.07.013","url":null,"abstract":"","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":" ","pages":"641-642"},"PeriodicalIF":2.6,"publicationDate":"2024-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142349879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Medicina ClinicaPub Date : 2024-12-27Epub Date: 2024-10-15DOI: 10.1016/j.medcli.2024.07.023
Christian Ruzafa Martinez, Salvador Valero, Eva García Villalba, Cristina Tomás, Ángeles Muñoz, Antonia Alcaraz, Rodrigo Martínez-Rodríguez, María Dolores Hernández, María Isabel Martínez, María Rosario Vicente, Elena Guijarro Westermeyer, Román González Hipólito, Enrique Bernal
{"title":"[Vaccine effectiveness in patients admitted for influenza during the 2023-2024 season].","authors":"Christian Ruzafa Martinez, Salvador Valero, Eva García Villalba, Cristina Tomás, Ángeles Muñoz, Antonia Alcaraz, Rodrigo Martínez-Rodríguez, María Dolores Hernández, María Isabel Martínez, María Rosario Vicente, Elena Guijarro Westermeyer, Román González Hipólito, Enrique Bernal","doi":"10.1016/j.medcli.2024.07.023","DOIUrl":"10.1016/j.medcli.2024.07.023","url":null,"abstract":"<p><strong>Background and goal: </strong>Vaccination against influenza is widespread worldwide, reducing complications associated with infection. However, the impact of vaccination on mortality/ICU admission in hospitalized patients has been little studied.</p><p><strong>Material and methods: </strong>A retrospective observational study was conducted on 238 patients hospitalized for influenza from October 2023 to January 2024 to evaluate the vaccine's effectiveness in terms of the combined event of ICU admission/mortality during hospitalization. Additionally, the characteristics of vaccinated patients and the existence of bacterial superinfection were analyzed. Cox regression was performed using the SPSS program and the free «R» software.</p><p><strong>Results: </strong>A total of 238 patients were included. Those vaccinated were older (78.2±8.8 vs 69.97±16.6years; P<.001) and were more likely to have hypertension (82.2% vs 56.2%; P<.001), cardiovascular disease (36.6% vs 24.1%; P=.05), chronic bronchopathy (25.7% vs 8.8%; P=.001), or chronic kidney disease (22.8% vs 8.8%; P=0.005). They had lower levels of CRP (8.39±9.55 vs 11.03±10.75mg/dl; P=.05), procalcitonin (0.62±1.74 vs 1.67±4.57ng/dl; P=.05), and SOFA scores (1.13±0.9 vs 1.39±0.97; P=0.033). 11 patients were admitted to ICU (4.6%) and 11 died (4.6%). Influenza vaccination was associated as a protective factor against ICU admission/mortality in the Cox regression (HR=0.216; 95%CI: 0.062-0.759, P=.017). The presence of bacterial superinfection was similar between vaccinated and unvaccinated patients (63.4% vs 67.9%; P=.556).</p><p><strong>Conclusions: </strong>Influenza vaccination may reduce the probability of ICU admission or death. This effect is likely due to better control of the immune response. We did not observe any relationship with the risk of presenting bacterial superinfection.</p>","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":" ","pages":"589-594"},"PeriodicalIF":2.6,"publicationDate":"2024-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142469876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Medicina ClinicaPub Date : 2024-12-27Epub Date: 2024-10-09DOI: 10.1016/j.medcli.2024.07.020
Carmen Riesco-Bárcena, José Ivorra-Cortés, Elena Grau-García, Luis González-Puig, Samuel Leal, Anderson Huaylla, José Román-Ivorra
{"title":"[Hyperparathyroidism in patients with low bone mineral density treated with zoledronic acid or denosumab].","authors":"Carmen Riesco-Bárcena, José Ivorra-Cortés, Elena Grau-García, Luis González-Puig, Samuel Leal, Anderson Huaylla, José Román-Ivorra","doi":"10.1016/j.medcli.2024.07.020","DOIUrl":"10.1016/j.medcli.2024.07.020","url":null,"abstract":"<p><strong>Objective: </strong>To analyze the prevalence of hyperparathyroidism in patients treated with zoledronic acid (ZA) or denosumab, its relationship with other parameters and how it affects on bone mineral density (BMD) evolution.</p><p><strong>Methods: </strong>Retrospective observational study in patients with osteoporosis or osteopenia and high risk of fracture, who have received denosumab or ZA for at least two years. Patients diagnosed with hyperparathyroidism or glomerular filtration rate <30ml/min at baseline visit were excluded from the study.</p><p><strong>Results: </strong>Ninety patients (ZA: 54.44%) were included. 18.36% of ZA-treated patients had elevated PTH levels at some time compared to 36.58% denosumab-treated patients (p>0.05). Patients with persistently elevated PTH were 6.13% in the AZ group and 19.51% in the denosumab group (p<0.04). We found a statistically significant inverse association between elevated PTH levels, glomerular filtration rate (p=0.007), and albumin-corrected calcium (p <0.001). We did not find an association between hyperparathyroidism and BMD evolution.</p><p><strong>Conclusions: </strong>A high incidence of hyperparathyroidism was observed in patients treated with AZ and especially denosumab. Hyperparathyroidism correlated inversely with glomerular filtration rate and albumin-corrected calcium. Elevated PTH does not appear to affect short-term bone mineral density evolution.</p>","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":" ","pages":"595-599"},"PeriodicalIF":2.6,"publicationDate":"2024-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142391767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Medicina ClinicaPub Date : 2024-12-27Epub Date: 2024-07-14DOI: 10.1016/j.medcli.2024.05.008
Joan Ramon Roma, Pedro Castro Rebollo, Carla Bastida
{"title":"[Sublingual and buccal drug administration in medical emergencies].","authors":"Joan Ramon Roma, Pedro Castro Rebollo, Carla Bastida","doi":"10.1016/j.medcli.2024.05.008","DOIUrl":"10.1016/j.medcli.2024.05.008","url":null,"abstract":"<p><p>Drug administration is crucial to achieve effective therapeutic drug outcomes. In medical emergencies, it is particularly convenient to use drugs that could be administered as an alternative to traditional routes (as oral or intravenous routes), that are not always suitable in these situations. Thus, sublingual and buccal routes offer an alternative to traditional routes, when a rapid onset of action is required. The main objective of this narrative review is to summarize the evidence for the use of sublingual and buccal drug administration in medical emergencies. The evidence obtained has been divided into four common scenarios found in the emergency department and intensive care units: cardiovascular emergencies, acute pain, agitation, and epileptic status. Moreover, the main advantages and disadvantages of sublingual and buccal routes are presented, as the future perspectives in the drug delivery field to overcome the limitations of these routes.</p>","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":" ","pages":"619-625"},"PeriodicalIF":2.6,"publicationDate":"2024-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141616800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Medicina ClinicaPub Date : 2024-12-27Epub Date: 2024-08-22DOI: 10.1016/j.medcli.2024.06.010
Miquel Àngel Mas
{"title":"Caring for patients with multiple chronic conditions: Moving from morbidities to person needs.","authors":"Miquel Àngel Mas","doi":"10.1016/j.medcli.2024.06.010","DOIUrl":"10.1016/j.medcli.2024.06.010","url":null,"abstract":"","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":" ","pages":"617-618"},"PeriodicalIF":2.6,"publicationDate":"2024-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142036282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}